Researcher | Research Overview
The D’Gama Lab conducts translational research at the intersection of developmental neuroscience, genetics/genomics, and neonatology. Our goal is to advance equitable precision medicine for infants and children with neurological and genetic conditions, especially infants with epilepsy and related neurogenetic disorders. We aim to accomplish this goal by conducting research across the translational spectrum: discovering fundamental underlying molecular genetic mechanisms (precision diagnoses) and evaluating their impact, enabling development of innovative precision therapies and readiness for clinical trials, and implementing precision medicine equitably for these populations. Ultimately, we hope to improve outcomes for pediatric patients with these conditions and their families.
Researcher | Research Background
Dr. D’Gama is an attending physician and principal investigator in the Division of Newborn Medicine at Boston Children’s Hospital, where she serves as Director of the Neonatal Neurogenetics Program, and an Instructor of Pediatrics at Harvard Medical School. She studied Molecular and Cellular Biology at Harvard College and then trained in the Harvard/MIT MD-PhD Program. During her PhD under the mentorship of Dr. Christopher Walsh, she studied germline and somatic variants in neurodevelopmental disorders. Dr. D’Gama completed pediatrics residency training in the Boston Combined Residency Program on the Accelerated Research Pathway and neonatal-perinatal medicine fellowship training in the Harvard Neonatal-Perinatal Medicine Fellowship Training Program, where she served as Chief Fellow. For her postdoctoral training in neurogenetics and neonatal genomics, she was mentored by Drs. Annapurna Poduri and Timothy Yu at Boston Children’s Hospital.